BioMarin Pharmaceutical

Details

  • Anzahl der Mitarbeiter
    1000-5000
  • Unternehmenstyp
    Globaler Konzern
About BioMarin Pharmaceutical

BioMarin Pharmaceutical is a leading biotechnology company focused on developing therapies for rare genetic diseases. Since its founding in 1997, the company has delivered innovative treatments for conditions such as achondroplasia, PKU, and CLN2, significantly improving the lives of patients with previously limited options. With the recent acquisition of Amicus, BioMarin has expanded its portfolio to include therapies for Fabry disease and Pompe disease, further enhancing its commitment to addressing unmet medical needs.

Career Opportunities

BioMarin Pharmaceutical offers a dynamic work environment that fosters professional growth and development. The company is dedicated to excellence and innovation, providing employees with the opportunity to make a meaningful impact in the lives of patients. BioMarin values collaboration and scientific expertise, creating a supportive atmosphere for its global teams.

  • Comprehensive benefits package
  • Opportunities for career advancement
  • Commitment to employee well-being
>